ReviewJournal of robotic surgery2019
Review of strategies and factors to maximize cost-effectiveness of robotic hysterectomies and myomectomies in benign gynecological disease.
Review in Journal of robotic surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Enhancing surgical performance: the role of robotic surgery in myomectomies, a systematic review and metanalysis.Journal of robotic surgery · 2024Pooled it
- Team-based learning curve and cost efficiency in robot-assisted hysterectomy: a four-phase CUSUM study of 915 cases.Journal of robotic surgery · 2025Article
- Analysis of sustainability strategies in cataract surgery and surgeon perspective in reducing carbon footprint.International ophthalmology · 2025Review
- Strategies for Sustainability and Cost Optimization in Corneal Transplantation: From Surgeons’ PerspectiveTurkish journal of ophthalmology · 2025Review
- Cost variance across obesity class for women undergoing laparoscopic hysterectomy by high-volume gynecologic surgeons.Journal of robotic surgery · 2020Article
- Robotic surgery during the COVID pandemic: why now and why for the future.Journal of robotic surgery · 2020Article
- Strategies for Cost Optimization in Minimally Invasive Gynecologic Surgery.JSLS : Journal of the Society of Laparoendoscopic SurgeonsReview
- Predictors of Minimally Invasive Myomectomy in the National Inpatient Sample Database, 2010-2014.JSLS : Journal of the Society of Laparoendoscopic SurgeonsArticle
- Robotic Hysterectomy for Benign Indications: What Have We Learned from a Decade?JSLS : Journal of the Society of Laparoendoscopic SurgeonsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Common benign gynecologic procedures include hysterectomies and myomectomies, with hysterectomy being the most common gynecologic procedure in the United States [1]. While historically performed via laparotomy, the field of gynecologic surgery was revolutionized with the advent of laparoscopic techniques, with the most recent advancement being the introduction of robotic-assisted surgery in 2005. Robotic surgery has all the benefits of laparoscopic surgery such as decreased blood loss, quicker return to activities, and shorter length of hospital stay. Additional robotic-specific advantages include but are not limited to improved ergonomics, 3D visualization, and intuitive surgical movements. Despite these advantages, one of the most commonly cited drawbacks of robotic surgery is the associated cost. While the initial cost to purchase the robotic console and its associated maintenance costs are relatively high, robotic surgery can be cost-effective when utilized correctly.This article reviews application strategies and factors that can offset traditional costs and maximize the benefits of robotic surgery.
Indexed as
Identifiers
30919259What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.